FF/UMEC/VI versus FF/VI and UMEC/VI in the ELLIPTA device in patients with COPD: Subgroup analyses from the IMPACT trial
D. Singh (Manchester, United Kingdom), F. Barnhart (Research Triangle Park, United States of America), N. Brealey (Uxbridge, United Kingdom), G. Criner (Philadelphia, United States of America), M. Dransfield (Birmingham, United States of America), D. Halpin (Exeter, United Kingdom), M. Han (Ann Arbor, United States of America), C. Jones (Research Triangle Park, United States of America), S. Kilbride (Uxbridge, United Kingdom), P. Lange (Copenhagen, Denmark), D. Lomas (London, United Kingdom), F. Martinez (New York, United States of America), D. Mouneimne (Brentford, United Kingdom), R. Wise (Baltimore, United States of America), D. Lipson (Philadelphia, United States of America)
Source: International Congress 2018 – COPD management
Session: COPD management
Session type: Thematic Poster
Number: 4383
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. Singh (Manchester, United Kingdom), F. Barnhart (Research Triangle Park, United States of America), N. Brealey (Uxbridge, United Kingdom), G. Criner (Philadelphia, United States of America), M. Dransfield (Birmingham, United States of America), D. Halpin (Exeter, United Kingdom), M. Han (Ann Arbor, United States of America), C. Jones (Research Triangle Park, United States of America), S. Kilbride (Uxbridge, United Kingdom), P. Lange (Copenhagen, Denmark), D. Lomas (London, United Kingdom), F. Martinez (New York, United States of America), D. Mouneimne (Brentford, United Kingdom), R. Wise (Baltimore, United States of America), D. Lipson (Philadelphia, United States of America). FF/UMEC/VI versus FF/VI and UMEC/VI in the ELLIPTA device in patients with COPD: Subgroup analyses from the IMPACT trial. 4383
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: